Assessment of fatigue and autonomic dysfunction in myasthenia gravis – case report by Kwiatkowska, Klaudia et al.
Kwiatkowska Klaudia, Lamtych Martyna, Kubiak Karolina, Litwa Ewelina, Badiuk Nataliia. Assessment of fatigue and autonomic
dysfunction in myasthenia gravis – case report. Journal of Education, Health and Sport. 2019;9(5):667-675. eISNN 2391-8306. DOI
http://dx.doi.org/10.5281/zenodo.3375836
http://ojs.ukw.edu.pl/index.php/johs/article/view/7322
The journal has had 7 points in Ministry of Science and Higher Education parametric evaluation. Part b item 1223 (26/01/2017).
1223 Journal of Education, Health and Sport eISSN 2391-8306 7
© The Author(s) 2019;
This article is published with open access at Licensee Open Journal Systems of Kazimierz Wielki University in Bydgoszcz, Poland
Open Access. This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium,
provided the original author (s) and source are credited. This is an open access article licensed under the terms of the Creative Commons Attribution Non commercial license
(http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted, non commercial use, distribution and reproduction in any medium, provided the work is properly cited.
This is an open access article licensed under the terms of the Creative Commons Attribution Non commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted, non commercial
use, distribution and reproduction in any medium, provided the work is properly cited.
The authors declare that there is no conflict of interests regarding the publication of this paper.
Received: 19.05.2019. Revised: 22.05.2019. Accepted: 31.05.2019.
Assessment of fatigue and autonomic dysfunction in myasthenia gravis –
case report
Klaudia Kwiatkowska1, Martyna Lamtych1, Karolina Kubiak1,
Ewelina Litwa2, Nataliia Badiuk3
1Student  Scientific  Circle  at  Chair  of  Hygiene,  Epidemiology and Ergonomics,  Faculty of  Health Sciences,
Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz, Poland
2Scientific  Circle  at  Department  of  Hygiene,  Epidemiology  and  Ergonomics.  Division  of  Ergonomics  and
Exercise Physiology, Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz, Poland
3State Enterprise Ukrainian Research Institute for Medicine of Transport, Ministry of Health of Ukraine, Odesa,
Ukraine
Abstract
Introduction: Myasthenia gravis (MG) is an autoimmune disease in which neuromuscular
conduction disorders occur. The reason is the loss of acetylcholine receptors and the presence
of  antibodies  directed  against  these  receptors.  The  most  characteristic  symptoms  of
myasthenia  gravis  are:  tenderness  and  weakness  of  striated  muscles,  which  intensify
particularly  during  exercise  and  in  the  evening.  Non-motor  symptoms  such  as:  fatigue,
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disorders  of  the  autonomic  nervous  system  can  be  asymptomatic,  and  in  a  significant
proportion of cases significantly affect the quality of life. A full understanding of non-motors
symptoms is  needed to treat  patients  with MG. The aim of the study was to  present  the
characteristics of non-motor symptoms on the example of a patient with myasthenia gravis.
Material  and methods: A 50-year-old woman who had been suffering  from myasthenia
gravis  for  23  years  was  examined.  Chalder  Fatigue  Scale,  Epworth  Sleepiness  Scale,
Orthostatic  Grading  Scale  were  used  to  evaluate  non-motor  symptoms.  The  orthostatic
reaction was tested using the tilt test.
Results: The most frequently reported non-motors symptoms in the patient  were: chronic
fatigue, sleep disturbances and cardiovascular symptoms (orthostatic intolerance, weakness).
Conclusions: Myasthenia  gravis  is  characterized  by  a  large  variability  of  symptoms.  An
important part of the clinical picture are non-motor symptoms that can affect the functioning
of patients in everyday life.
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Introduction
Myasthenia gravis (MG) is one of the autoimmune diseases in which neuromuscular
transmission disorders occur. The disease is in many cases late diagnosed by a heterogeneous
clinical picture. The most characteristic symptoms for MG are excessive fatigue and muscle
weakness, however, many patients may have additional non-motor symptoms such as fatigue
or disorders of the autonomic nervous system [1, 2].
Fatigue  is  a  subjective  symptom  accompanied  by  a  feeling  of  general  weakness.
Occurs as an additional symptom of neurological (Parkinson's disease, Multiple Sclerosis),
cardiovascular or neuromuscular diseases. Fatigue in patients with myasthenia gravis has not
been as well understood as in other diseases. The reason may be that it is often confused with
muscular fatigue, which is very characteristic for MG [3, 4].
Similar to fatigue, autonomic dysfunction has been well known in many other disease
entities  -  including in multiple  sclerosis,  Parkinson's  disease,  Guillain-Barry syndrome,  in
cerebrovascular disease. In the available publications, the authors notice that symptoms such
as heat intolerance, sweating disorders, orthostatic hypotension, urinary and sexual disorders,
excessive  dryness  or  diarrhea  and  constipation  are  also  present  in  many  patients  with
myasthenia gravis. However, these are not symptoms characteristic of MG, they are often
asymptomatic. They are difficult to diagnose [2, 5, 6].
Case report
A  woman  aged  50,  suffering  from  myasthenia  gravis  for  23  years.  Currently
unemployed,  currently  on  a  pension.  In  the  interview,  the  patient  reported  arthralgia,
progressive muscular weakness of the lower limbs and excessive fatigue, which is intensified
under  the  influence  of  physical  activity.  A  patient  walking  alone,  without  orthopedic
assistance. Additional overweight (BMI - 27.7; height - 159 cm; weight - 70 kg).
In the  assessment  of  autonomic  disorders,  the  patient  reported  such symptoms  as:
orthostatic disorders, arrhythmia, dizziness, thermoregulation disorders, dry eyes and mouth,
sleep disorders and secretory disorders (Table 1).
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Assessment of fatigue and autonomic nervous system functions
Chalder Fatigue Scale (CFS) was used to assess fatigue. It is a questionnaire consisting
of 11 questions, of which the first seven are related to physical fatigue, the last seven are
about mental fatigue [7]. The Epworth Sleepiness Scale (ESS) was used to assess sleepiness.
This scale assesses the possibility of falling asleep in 8 everyday situations on a scale of 0
(impossible to sleep) to 3 (high probability of falling asleep). The higher the result achieved,
the greater the tendency to fall asleep in everyday life [8].
The orthostatic reaction was tested by tilt test using Task Force Monitor® (TFM). It is
a non-invasive method by which the autonomic and cardiovascular systems can be assessed.
TFM consists of the following elements [9, 10]:
- impedance cardiography (IKG),
- pulse oximeter
- a device for continuous measurement of blood pressure,
- electrocardiograph,
- device for oscillometric blood pressure measurement.
The verticalization to 70 degrees took 5.20 minutes. The following parameters were
analyzed: heart rate (HR), systolic blood pressure (sBP), diastolic blood pressure (dBP) and
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mean blood pressure (mBP). The patient was informed about the methodology of the study,
which she agreed to.
Additionally, the 5-point OGS (Orthostatic Grading Scale) questionnaire was used to
assess  the  symptoms  of  orthostatic  intolerance.  The  result  obtained  by  the  respondent  is
proportional to orthostatic intolerance [11].
Results
The body's physiological response to passive standing is to increase the heart rate (by
up to 30%). Mean blood pressure does not change much [5]. The patient had an increase in
the parameters studied, however, the increase in heart  rate was very small,  which may be
manifested in the patient by dizziness or orthostatic intolerance (Fig. 1).









Before tilt test During tilt test
Figure 1. Hemodynamic values before and during the tilt test.
The results obtained in the tilt test are confirmed by the interview with the subject,
who  reported  symptoms  from  the  autonomic  system  -  including  orthostatic  disorders,
dizziness and arrhythmia (table 1).
The results of the questionnaires along with the interpretation are presented in Table 2.
In CFS, the patient scored 16 points, which indicates excessive fatigue and weakness. ESS
analysis  does  not  indicate  excessive  sleepiness  (4  points  obtained).  In  addition,  in  the
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Orthostatic  Grading  Scale,  assessing  the  symptoms  of  orthostatic  intolerance,  the  subject
obtained 12 points out of 20 possible.
Table 2. Assessment of non-motor symptoms using OGS, CFS, ESS.
Scale Score Interpretation
Orthostatic Grading Scale 
(OGS)
12   the higher the score, the
greater the orthostatic 
intolerance;
  maximum number of 
points: 20.
Chalder Fatigue Scale 
(CFS)




4 A score of 0-5 is no 
excessive sleepiness.
Discussion 
The  test  organism's  response  to  the  tilt  test,  the  results  obtained  in  individual
questionnaires and the interview signalize a reduced of the orthostatic reaction and may signal
disorders of the autonomic nervous system (orthostatic disorders, arrhythmia, dizziness, dry
eyes and mouth, secretory disorders, sleep disorders , anxiety disorders and thermoregulation
disorders)  and excessive  fatigue.  Currently,  there  are  more  and more scientific  studies  in
which the authors raise the issue of fatigue and other non-motor symptoms in myasthenia
gravis. Clinicians note that these are significant problems in this group of patients, negatively
affecting the patient's quality of life [12-16].
In  a  prospective  study,  Nikolić  et  al.  [12]  compared  the  incidence  of  autonomic
disorders due to the presence of antibodies and thymus disorders. In the group of patients with
anti-acetylcholine  receptor  (anti-AChR) antibodies  and thymoma,  symptoms of  autonomic
dysfunction were in 86% of patients,  with the most common occurrence:  heat intolerance
(76%), urinary bladder dysfunctions (81%) and sexual disorders (67%). Autonomic disorders
in  patients  with  anti-AChR positive  antibodies,  but  without  thymoma  -  were  in  57% of
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patients.  In  turn,  in  patients  with  anti-MuSK  (anti-tyrosine  kinase  antibodies)  the  most
common disorders were dizziness (39%), heat intolerance (30%) as well as dry mouth and
sexual dysfunction - present in 26% of respondents. In the study by Elsais et al. [13], the most
frequently reported symptoms of autonomic dysfunction in myasthenia gravis were excessive
dryness (50%) and sleep disturbance (46%) and orthostatic  disorder (44%). 32% reported
vascular disorders, while food disorders - 22%.
Hoffmann et al. [14] used Chalder Fatigue Scale to assess fatigue. For 110 people with
myasthenia  gravis  participating  in  the  study,  excessive  fatigue  was  found  in  56.1%  of
respondents. Elsais et al. [13] based on the same questionnaire noted the occurrence of fatigue
in 44% of respondents. Alekseeva et  al.  [15] examined 73 people with myasthenia gravis
using the FSS (Fatigue Severity Scale) questionnaire.  Fatigue was found in up to 70% of
respondents. In another study, Paul et al. [16] observed fatigue in 82% of patients with MG.
Non-motor symptoms, including disorders of the autonomic nervous system, are a big
problem  for  patients  with  myasthenia  gravis.  These  are  not  characteristic  symptoms  of
myasthenia  gravis,  they  are  often  asymptomatic  and  therefore  their  diagnosis  may  be  a
problem.
Conclusions 
Myasthenia  gravis  is  a  disease  characterized  by  a  large  variability  and  variety  of
symptoms. An important part of the clinical picture are non-motor symptoms such as chronic
fatigue, sleep disturbances, orthostatic intolerance, weakness or thermoregulation disorders.
They can affect the functioning of patients in everyday life.
All  symptoms should be considered when diagnosing myasthenia gravis  and when
planning comprehensive therapeutic management.
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